Other Biochemicals - LDN 193189 (CAS: 1062368-24-4)

Location：Home > Biochemicals > Other Biochemicals

LDN 193189 (CAS: 1062368-24-4)

Catalog #：EBC51133

Datasheet

LDN 193189 (CAS: 1062368-24-4)

SKU-Pack Size	Availability	Size	Price
EBC51133-1MG	In Stock	1mg	$88.50
EBC51133-5MG	In Stock	5mg	$118.50
EBC51133-10MG	In Stock	10mg	$193.50
EBC51133-25MG	In Stock	25mg	$358.50
EBC51133-50MG	In Stock	50mg	$598.50

If you want to get a larger packsize, Please contact your local distributor or
email us atinfo@ebiocell.com

Please Select The Country You Are In To Find Your Local Distributor.

	EbioCell	Phone：(540) 808-3925
	Imperial Business Park 4819 Emperor Boulevard,	E-mail：order@ebiocell.com
United States	Suite 408 Durham, NC 27703, USA	Web：www.ebiocell.com

Product Information

Synonym(s)

LDN 193189, LDN-193189, DM-3189

Chemical Name

4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline

Application

LDN193189 is a selective transcriptional activity morphogenetic protein (BMP) type I receptors inhibitor

CAS Number

1062368-24-4

Purity

≥98.0%

Molecular Weight

406.48

Molecular Formula

C₂₅H₂₂N₆

SMILES

C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3

Target & IC50

ALK2: IC50 = 5 nM
ALK3: IC50 = 30 nM

Solubility

DMSO : 12 mg/mL (29.52 mM; ultrasonic and adjust pH to 2 with HCl)
Ethanol : 1 mg/mL (2.46 mM; Need ultrasonic)

Preparing Stock Solutions

ConcentrationSolventMass	1 mg	5 mg	10 mg
1 mM	2.4601 ml	12.3007 ml	24.6015 ml
5 mM	0.4920 ml	2.4601 ml	4.9203 ml
10 mM	0.2460 ml	1.2301 ml	2.4602 ml
50 mM	0.0492 ml	0.2460 ml	0.4920 ml

Shipping

Gel Pack

Storage

Store at -20°C

Research Use

For Research Use Only. Not Intended for Diagnostic Or Therapeutic Use.

Product Description

LDN 193189 inhibits the activity of the Bone Morphogenetic Protein (BMP) type I receptors ALK2 and ALK3 with IC₅₀ values of 5 nM and 30 nM respectively and shows weaker effects on activin and the TGF-β type I receptors ALK4, ALK5 and ALK7 (IC₅₀≥ 500 nM). It inhibits the activation of the BMP signaling effectors SMAD1, SMAD5 and SMAD8 in a dose-dependent manner in C2C12 cells. LDN-193189 significantly reduces tumor growth in SCID mice bearing MDA-PCa-118b tumors

Specific Protocols

>>	Western Blotting Protocol	>>	Immunoprecipitation Protocol
>>	Immunohistochemistry Protocol	>>	Immunofluorescence Protocol
>>	Immunocytochemistry Protocol	>>	Flow Cytometry Protocol
>>	ChIP Protocol	>>	ELISA Protocol
>>	HPLC Protocol	>>	PCR Protocol